Friedl-Naderer Johanna 4
4 · Vir Biotechnology, Inc. · Filed Mar 7, 2023
Insider Transaction Report
Form 4
Friedl-Naderer Johanna
Chief Business Officer, Global
Transactions
- Sale
Common Stock
2023-03-03$22.82/sh−1,482$33,819→ 148,518 total
Footnotes (1)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.